As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters ...

Discover the latest developments in the neuroplastogens field, including Elkedonia’s funding to address neuropsychiatric ...

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live ...

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions. Please check event websites for further ...

In 2020, Novo Nordisk’s Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired. The reason? A small missed maintenance fee, ...

The advent of “gepants” for migraines. The role of CGRP in migraines, specifically its involvement in pain and inflammation during migraine attacks, was first hypothesized around 1983 and later ...

Immunotherapies in high demand; fueling R&D. The immunotherapy market size was valued at $226.38 billion last year, and it is only projected to grow by almost 12% by 2030, according to Grand View ...